Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Decreased telomere length in a subgroup of young individuals with bipolar disorders: replication in the FACE-BD cohort and association with the shelterin component POT1.
Spano L, Marie-Claire C, Godin O, Lebras A, Courtin C, Laplanche JL, Leboyer M, Aouizerate B, Lefrere A, Belzeaux R, Courtet P, Olié E, Dubertret C, Schwan R, Aubin V, Roux P, Polosan M, Samalin L, Haffen E; Fondamental Advanced Centers Of Expertise In Bipolar Disorders (Face-Bd) Collaborators; Bellivier F, Etain B. Spano L, et al. Transl Psychiatry. 2024 Mar 1;14(1):131. doi: 10.1038/s41398-024-02824-z. Transl Psychiatry. 2024. PMID: 38429270 Free PMC article.
Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment and self-reported side effects in the euthymic phase of bipolar disorders: Results from the FACE-BD cohort.
Vidal N, Brunet-Gouet E, Frileux S, Aouizerate B, Aubin V, Belzeaux R, Courtet P, D'Amato T, Dubertret C, Etain B, Haffen E, Januel D, Leboyer M, Lefrere A, Llorca PM, Marlinge E, Olié E, Polosan M, Schwan R, Walter M; FACE-BD (FondaMental Academic Centers of Expertise for Bipolar Disorders) group; Passerieux C, Roux P. Vidal N, et al. Eur Neuropsychopharmacol. 2023 Dec;77:67-79. doi: 10.1016/j.euroneuro.2023.08.502. Epub 2023 Sep 21. Eur Neuropsychopharmacol. 2023. PMID: 37741163 Review.
A scoping review on innovative methods for personality observation.
Mosca LL, Continisio GI, De Lucia N, Gigante E, Guerriera C, Maldonato NM, Moretto E, Ragozzino O, Rosa V, Scognamiglio C, Stanzione R, Cantone D. Mosca LL, et al. Among authors: scognamiglio c. Front Psychol. 2023 Mar 8;14:1112287. doi: 10.3389/fpsyg.2023.1112287. eCollection 2023. Front Psychol. 2023. PMID: 36968705 Free PMC article. Review.
Modelling skeletal pain harnessing tissue engineering.
Iafrate L, Benedetti MC, Donsante S, Rosa A, Corsi A, Oreffo ROC, Riminucci M, Ruocco G, Scognamiglio C, Cidonio G. Iafrate L, et al. Among authors: scognamiglio c. In Vitro Model. 2022;1(4-5):289-307. doi: 10.1007/s44164-022-00028-7. Epub 2022 Aug 4. In Vitro Model. 2022. PMID: 36567849 Free PMC article. Review.
Current (but not ex) cigarette smoking is associated with worse cognitive performances in schizophrenia: results from the FACE-SZ cohort.
Mallet J, Godin O, Dansou Y, Mazer N, Scognamiglio C, Berna F, Boyer L, Capdevielle D, Chéreau I, D'Amato T, Dubreucq J, Fond G, Leigner S, Llorca PM, Misdrahi D, Passerieux C, Rey R, Pignon B, Urbach M, Schorr B, Schürhoff F, Yann LS, Dubertret C; FACE-SZ (FondaMental Academic Center of Expertise for Schizophrenia) Group. Mallet J, et al. Among authors: scognamiglio c. Psychol Med. 2023 Aug;53(11):5279-5290. doi: 10.1017/S0033291722002574. Epub 2022 Sep 8. Psychol Med. 2023. PMID: 36073848
28 results